We want to build the personalised medicine of tomorrow, accessible to every biologist, physician and healthcare professional.We believe this quantum leap will take place within a few years through the wide adoption of multi-omics and digital PCR technologies. Fasma is developing the leading bio-informatics platform to analyse these new data.